• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

ATL expects flat Q3 revenues

Article

Ultrasound vendor ATL reported lastweek that it is not expecting any improvement in third-quarterrevenues due to ongoing difficult market conditions in the U.S.and Europe. According to preliminary internal estimates conductedby the Bothell, WA-based

Ultrasound vendor ATL reported lastweek that it is not expecting any improvement in third-quarterrevenues due to ongoing difficult market conditions in the U.S.and Europe. According to preliminary internal estimates conductedby the Bothell, WA-based company, third-quarter revenues willprobably be similar to, but will not exceed, those of the secondquarter of this year. ATL reported second-quarter revenue of $84.8million, down 5% compared to the same period a year ago (SCAN8/10/94).

ATL is pinning hopes for a recovery in part on Apogee 800,a mid-range scanner acquired through the vendor's merger withInterspec. ATL is in the midst of a worldwide roll-out of theproduct.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.